Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

LORDSTOWN, Ohio - A workforce reduction began today at the Ultium Cells battery manufacturing plant in Lordstown. The company moved forward with a planned mass layoff involving 1,334 hourly employees.

CEO Brian Culley highlighted the progress of OpRegen, noting its differentiation from current anti-complement therapies for dry AMD. He emphasized, “OpRegen has shown evidence of both anatomical and ...